Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A2BP1 gene polymorphisms association with olanzapine-induced weight gain.

Pharmacological research - 1 Sept 2015

Dong Licai, Yan Hao, Huang Xuebing, Hu Xiaofeng, Yang Yongfeng, Ma Cuicui, Du Bo, Lu Tianlan, Jin Chao, Wang Lifang, Yu Hao, Dong Zheng, Li Wenqiang, Ruan Yanyan, Zhang Hongyan, Zhang Hongxing, Mi Weifeng, Ma Wenbin, Li Keqing, Lv Luxian, Zhang Dai, Yue Weihua

Abstract excerpt

The ataxin-2 binding protein 1 (A2BP1) gene is reported to be one of the susceptibility genes in schizophrenia, autism, and obesity. The aim of this study was to explore the association of A2BP1 gene polymorphisms with antipsychotic induced weight gain (AIWG) in Chinese Han population. Three hundred and twenty-eight patients with schizophrenia were followed-up for an 8-week period of treatment with olanzapine....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Benzodiazepines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Olanzapine

Share to RNA-Binding Proteins

Share to RNA Splicing Factors

Share to Schizophrenia

Share to Tissue Distribution

Share to Weight Gain

Source

Identifiers

PMID: 26092620
DOI: 10.1016/j.phrs.2015.06.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A2BP1 gene polymorphisms association with olanzapine-induced weight gain.PMID 26092620Read ↗

Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.Semantic proximity Read ↗

Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain.Semantic proximity Read ↗

Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.Semantic proximity Read ↗

Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment.Semantic proximity Read ↗

A meta-analysis of potential genetic factors associated with antipsychotic-induced weight gain in adults with severe mental illness.Semantic proximity Read ↗

Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed.Semantic proximity Read ↗

Genome-wide association study implicates lipid pathway dysfunction in antipsychotic-induced weight gain: multi-ancestry validation.Semantic proximity Read ↗

Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample.Semantic proximity Read ↗

TOX and ADIPOQ Gene Polymorphisms Are Associated with Antipsychotic-Induced Weight Gain in Han Chinese.Semantic proximity Read ↗

Genome-Wide Association Study Suggested the PTPRD Polymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications.Semantic proximity Read ↗

Association of orexin receptor polymorphisms with antipsychotic-induced weight gain.Semantic proximity Read ↗

Association study of GABAA α2 receptor subunit gene variants in antipsychotic-associated weight gain.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.